Post Doctoral Scientist - Molecular Pharmacology
Eli Lilly and Company
June 25, 2026
On-site
Indianapolis, IN
Clinical Research and Development
Post-Doctoral Scientist - Molecular Pharmacology
In this role, you will:
- Conduct innovative molecular pharmacology studies to characterize GPCR ligand mechanisms of action across therapeutic receptor systems.
- Work with and be mentored by molecular pharmacologists, structural biologists, computational scientists, and medicinal chemists.
- Present findings at internal/external scientific meetings and publish in peer-reviewed journals.
Basic qualifications:
- PhD in pharmacology, biochemistry, biophysics, molecular biology, or a closely related life science discipline (all completed requirements by Oct 2026).
- Authorization to work in the United States full-time; Lilly will not sponsor visas/work authorization.
Additional skills/preferences:
- Background in membrane receptor biology, receptor pharmacology, signal transduction, or quantitative pharmacology.
- Self-directed, motivated; strong oral/written communication and publication goals.
- Data analysis/reporting skills (GraphPad Prism, Python, Excel, PyMOL, MOE).
- Ligand binding (competition/saturation/kinetic assays) in live cell or membrane formats.
- Experience with GPCR signaling assays (cAMP, IP1, Ξ²-arrestin recruitment, calcium, phosphoprotein).
- Familiarity with quantitative pharmacological modeling/kinetic simulation; mammalian cell culture and molecular biology; structural/computational biology.
Additional information:
- Onsite in Indianapolis, Indiana; fixed-term up to 2 years with possible 2-year extension.
Compensation/benefits (high level):
- Anticipated wage: $58,000β$123,200; eligible for company bonus and comprehensive benefits (e.g., 401(k), medical/dental/vision, life insurance, time off, well-being benefits).
In this role, you will:
- Conduct innovative molecular pharmacology studies to characterize GPCR ligand mechanisms of action across therapeutic receptor systems.
- Work with and be mentored by molecular pharmacologists, structural biologists, computational scientists, and medicinal chemists.
- Present findings at internal/external scientific meetings and publish in peer-reviewed journals.
Basic qualifications:
- PhD in pharmacology, biochemistry, biophysics, molecular biology, or a closely related life science discipline (all completed requirements by Oct 2026).
- Authorization to work in the United States full-time; Lilly will not sponsor visas/work authorization.
Additional skills/preferences:
- Background in membrane receptor biology, receptor pharmacology, signal transduction, or quantitative pharmacology.
- Self-directed, motivated; strong oral/written communication and publication goals.
- Data analysis/reporting skills (GraphPad Prism, Python, Excel, PyMOL, MOE).
- Ligand binding (competition/saturation/kinetic assays) in live cell or membrane formats.
- Experience with GPCR signaling assays (cAMP, IP1, Ξ²-arrestin recruitment, calcium, phosphoprotein).
- Familiarity with quantitative pharmacological modeling/kinetic simulation; mammalian cell culture and molecular biology; structural/computational biology.
Additional information:
- Onsite in Indianapolis, Indiana; fixed-term up to 2 years with possible 2-year extension.
Compensation/benefits (high level):
- Anticipated wage: $58,000β$123,200; eligible for company bonus and comprehensive benefits (e.g., 401(k), medical/dental/vision, life insurance, time off, well-being benefits).